Blood loss and allogeneic transfusion for surgical treatment of periprosthetic joint infection: a comparison of one- vs. two-stage exchange total hip arthroplasty.
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ administration & dosage
Arthritis, Infectious
/ etiology
Arthroplasty, Replacement, Hip
/ adverse effects
Blood Loss, Surgical
Blood Transfusion
Female
Hip Prosthesis
/ microbiology
Humans
Male
Middle Aged
Prosthesis-Related Infections
/ etiology
Reoperation
Retrospective Studies
Allogeneic blood transfusion
Blood loss
One-stage exchange
Two-stage exchange
Journal
International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
13
03
2018
accepted:
29
08
2018
pubmed:
7
9
2018
medline:
21
5
2020
entrez:
7
9
2018
Statut:
ppublish
Résumé
The purpose of the current study was to compare the blood loss and the need for allogeneic transfusion after one- and two-stage exchange arthroplasty for periprosthetic joint infection (PJI) of THA. We performed a retrospective review of all patients undergoing either one-stage or two-stage septic exchange arthroplasty at two high-volume infection referral centres. The study cohort consists of 90 patients undergoing the two-stage and 184 patients the one-stage exchange arthroplasty. The difference between pre- and post-operative haemoglobin (Hb) and total blood loss as well as the allogeneic transfusion rate were compared between both groups. Both procedures together of the two-stage septic exchange arthroplasty had higher intra-operative blood loss and allogeneic blood transfusion rate compared to the one-stage septic exchange arthroplasty group. However, among the patients of the two-stage group, there were more smokers and had worse physical status (ASA) and higher mortality risk (CCI) than patients in the one-stage group. Two-stage septic revision of total hip arthroplasty has higher rates of blood loss and transfusion rates than one-stage revision. Therefore, the authors believe that blood loss rate, including its complications, should be considered when decision for the type of staged septic exchange is made.
Identifiants
pubmed: 30187096
doi: 10.1007/s00264-018-4137-y
pii: 10.1007/s00264-018-4137-y
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2025-2030Références
Lancet. 1996 Oct 19;348(9034):1055-60
pubmed: 8874456
J Bone Joint Surg Am. 2004 Jul;86(7):1512-8
pubmed: 15252101
Trials. 2016 Feb 17;17:90
pubmed: 26883420
Open Orthop J. 2013 Jun 14;7:184-9
pubmed: 23898350
Int Orthop. 2018 Mar;42(3):469-477
pubmed: 29397413
J Arthroplasty. 2014 Jun;29(6):1298-300
pubmed: 24412146
Clin Orthop Relat Res. 2014 Mar;472(3):1036-42
pubmed: 24057192
J Arthroplasty. 2013 Sep;28(8 Suppl):66-70
pubmed: 23972299
J Bone Joint Surg Br. 1981;63-B(3):342-53
pubmed: 7021561
Orthop Clin North Am. 2016 Jan;47(1):11-8
pubmed: 26614916
Int Orthop. 2008 Jun;32(3):325-9
pubmed: 17396259
J Arthroplasty. 2017 Jan;32(1):214-219.e1
pubmed: 27503696
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Transfusion. 2003 Dec;43(12):1717-22
pubmed: 14641869
Int Orthop. 2014 Aug;38(8):1603-8
pubmed: 24817099
Orthop Traumatol Surg Res. 2013 Sep;99(5):555-61
pubmed: 23891660
Int Orthop. 2016 May;40(5):913-8
pubmed: 26224611
J Arthroplasty. 2017 Jul;32(7):2051-2055
pubmed: 28390887
Int Orthop. 2018 Mar;42(3):729-730
pubmed: 29297104
J Bone Joint Surg Am. 2004 Jan;86(1):57-61
pubmed: 14711946
Open Orthop J. 2016 Nov 30;10:646-653
pubmed: 28144374